Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The α-gal Syndrome - Investigating Immune Reactions to Tick Bites Leading to Inflammation and Allergic Sensitization

NCT07177729 is registered in ClinicalTrials.gov with Luxembourg Institute of Health as lead sponsor.

NCT NCT07177729
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07177729 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The α-gal Syndrome - Investigating Immune Reactions to Tick Bites Leading to Inflammation and Allergic Sensitization
Lead sponsor
Luxembourg Institute of Health
Phase
Observational
Overall status
Recruiting
Start date
July 1, 2025
Completion date
February 28, 2027
Enrollment
100 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

alpha-gal syndrome